128 related articles for article (PubMed ID: 23715575)
1. Irreversible myelopathy associated with nelaribine in T-cell acute lymphoblastic leukemia.
Gollard RP; Selco S
J Clin Oncol; 2013 Jul; 31(19):e327-31. PubMed ID: 23715575
[No Abstract] [Full Text] [Related]
2. Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient.
Papayannidis C; Iacobucci I; Abbenante MC; Curti A; Paolini S; Parisi S; Baccarani M; Martinelli G
Am J Hematol; 2010 Aug; 85(8):608. PubMed ID: 20658590
[No Abstract] [Full Text] [Related]
3. Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia.
Hartz B; Löbel U; Hagel C; Escherich G
Am J Hematol; 2013 Dec; 88(12):1096-7. PubMed ID: 23873785
[No Abstract] [Full Text] [Related]
4. Severe, reversible nelarabine-induced neuropathy and myelopathy.
Alberti P; Parma M; Pioltelli P; Pogliani EM; Terruzzi E; Stasia A; Doni E; Cecchetti C; Cavaletti G
J Peripher Nerv Syst; 2016 Sep; 21(3):154-6. PubMed ID: 27117493
[No Abstract] [Full Text] [Related]
5. Pediatric T-ALL complicated by irreversible nelarabine neurotoxicity.
Kanayama T; Imamura T; Nakagawa N; Osone S; Hosoi H
Pediatr Int; 2017 Jul; 59(7):843-845. PubMed ID: 28745456
[No Abstract] [Full Text] [Related]
6. Methotrexate-induced myelopathy mimicking subacute combined degeneration of the spinal cord.
Gosavi T; Diong CP; Lim SH
J Clin Neurosci; 2013 Jul; 20(7):1025-6. PubMed ID: 23647709
[TBL] [Abstract][Full Text] [Related]
7. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
Counsel P; Khangure M
Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
[No Abstract] [Full Text] [Related]
8. The effect of cerebral spinal fluid replacement on acute myelopathy induced by intrathecal therapy of leukemia.
Wang Z; Xu W; Liu L; Ding Z
Leuk Res; 2011 Jun; 35(6):e79-80. PubMed ID: 21247632
[No Abstract] [Full Text] [Related]
9. The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience.
Jain P; Kantarjian H; Ravandi F; Thomas D; O'Brien S; Kadia T; Burger J; Borthakur G; Daver N; Jabbour E; Konopleva M; Cortes J; Pemmaraju N; Kelly MA; Cardenas-Turanzas M; Garris R; Faderl S
Leukemia; 2014 Apr; 28(4):973-5. PubMed ID: 24157581
[No Abstract] [Full Text] [Related]
10. Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia.
von der Weid NX; de Crousaz H; Beck D; Deonna T; Miklossy J; Janzer RC
Med Pediatr Oncol; 1991; 19(3):192-8. PubMed ID: 2023567
[TBL] [Abstract][Full Text] [Related]
11. Nelarabine-associated myelopathy in a patient with acute lymphoblastic leukaemia: Case report.
Amer-Salas N; González-Morcillo G; Rodríguez-Camacho JM; Cladera-Serra A
J Oncol Pharm Pract; 2021 Jan; 27(1):244-249. PubMed ID: 32517638
[TBL] [Abstract][Full Text] [Related]
12. The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
McGregor BA; Brown AW; Osswald MB; Savona MR
Am J Hematol; 2009 Apr; 84(4):228-30. PubMed ID: 19260120
[TBL] [Abstract][Full Text] [Related]
13. Spinal Cord Toxicity from Intrathecal Chemotherapy: A Case with Clinicopathologic Correlation.
Dornbos D; Elder JB; Otero JJ; Baiocchi RA; Slone HW; Puduvalli VK; Giglio P
World Neurosurg; 2019 Aug; 128():381-384. PubMed ID: 31128312
[TBL] [Abstract][Full Text] [Related]
14. Myelopathy following intrathecal chemotherapy in adults: a single institution experience.
Cachia D; Kamiya-Matsuoka C; Pinnix CC; Chi L; Kantarjian HM; Cortes JE; Daver N; Woodman K
J Neurooncol; 2015 Apr; 122(2):391-8. PubMed ID: 25666482
[TBL] [Abstract][Full Text] [Related]
15. Brief report: chronic myelopathy after combined chemo-radiotherapy in a patient with relapsed mediastinal B-cell lymphoma.
Dormann S; Duffner U; Martini C; Böhm N; Korinthenberg R; Niemeyer C
Med Pediatr Oncol; 2002 Jun; 38(6):442-4. PubMed ID: 11984808
[No Abstract] [Full Text] [Related]
16. Transverse myelopathy following intrathecal administration of chemotherapy.
Teh HS; Fadilah SA; Leong CF
Singapore Med J; 2007 Feb; 48(2):e46-9. PubMed ID: 17304378
[TBL] [Abstract][Full Text] [Related]
17. [Case of precursor T-lymphoblastic lymphoma/leukemia diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration].
Ohkubo R; Izumo T; Ochiai K; Kirishi S; Tamaoki J; Nagai A
Nihon Kokyuki Gakkai Zasshi; 2010 Dec; 48(12):955-9. PubMed ID: 21226304
[TBL] [Abstract][Full Text] [Related]
18. Nelarabine-associated reversible Guillain-Barré-like syndrome or myelopathy in an adult patient with primary refractory T-lymphoblastic lymphoma.
Lalayanni C; Baldoumi E; Papayiannopoulos S; Tziola K; Saloum R; Anagnostopoulos A
Curr Probl Cancer; 2017; 41(2):138-143. PubMed ID: 28169005
[TBL] [Abstract][Full Text] [Related]
19. Acute ascending motoric paraplegia following intrathecal chemotherapy for treatment of acute lymphoblastic leukemia in children: case reports and review of the literature.
Rolf N; Boehm H; Kaindl AM; Lauterbach I; Suttorp M
Klin Padiatr; 2006; 218(6):350-4. PubMed ID: 17080338
[TBL] [Abstract][Full Text] [Related]
20. Dorsal myelopathy after nelarabine and intrathecal methotrexate therapy.
Sawamura F; Natsume J; Nakata T; Muramatsu H; Takahashi Y
Pediatr Int; 2022 Jan; 64(1):e15334. PubMed ID: 36331221
[No Abstract] [Full Text] [Related]
[Next] [New Search]